EMPLOYMENT OF NANOROBOTS IN CARDIOTHORACIC SURGERY www.ibrahimimbarak75@gmail.com

 

EMPLOYMENT OF NANOROBOTS IN CARDIOTHORACIC SURGERY

1

Libya

Oral only

Cardiothoracic surgery involves complex operations on the heart and lungs, often associated with high risks and extended recovery periods. Nanorobots—microscopic devices capable of operating at the cellular level—present a transformative opportunity to enhance surgical precision, reduce invasiveness, and improve patient outcomes.

The research combined 40% in vitro experimental work, 25% early-stage clinical simulations, and 35% in vivo studies using mouse models. Materials included DNA-based nanorobots, gold nanoparticles, magnetic nanomaterials, and polymeric carriers. Rodents were employed to assess biocompatibility, targeting accuracy, and therapeutic efficacy. Prior studies—such as a 2018 Nature Nanotechnology trial—showed over 70% vascular targeting success in mice, supporting the methodology.

Nanorobots demonstrated high precision in drug delivery, thrombus removal, tissue regeneration, and real-time diagnostics. Their use significantly reduced invasiveness and improved procedural outcomes.

Nanorobots hold exceptional potential in cardiothoracic surgery. Preclinical findings support their role in personalized, minimally invasive interventions. Further development is needed to address biocompatibility, control mechanisms, and regulatory approval for clinical use.